SEC Form 4 · accession 0001395064-26-000340
TAKEDA PHARMACEUTICAL CO LTD · TAK
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Lauren Rusckowski Duprey
Officer — Chief Transformation Officer
Period of report
Sep 14, 2026
Accepted (ET)
Sep 15, 2026 · 9:12 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001395064
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| American Depositary Shares | Sep 14, 2026 | S | 34,535 | $18.54 | D | 191,522 | D |
Table II — derivative securities
No Table II lines on this filing.